|
Volumn 301, Issue 7, 2009, Pages 710-711
|
Long-term risks of bisphosphonates probed
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
VITAMIN D;
ZOLEDRONIC ACID;
BONE DENSITY CONSERVATION AGENT;
ESOPHAGUS CANCER;
FEMUR FRACTURE;
FEMUR SHAFT FRACTURE;
FEMUR SUBTROCHANTERIC FRACTURE;
HEART ATRIUM FIBRILLATION;
HUMAN;
JAW OSTEONECROSIS;
LONG TERM CARE;
MUSCULOSKELETAL PAIN;
OSTEOLYSIS;
OSTEOPOROSIS;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT DURATION;
BONE NECROSIS;
CHEMICALLY INDUCED DISORDER;
ESOPHAGUS TUMOR;
HIP FRACTURE;
JAW;
NOTE;
ORAL DRUG ADMINISTRATION;
PAIN;
PATHOLOGY;
ADMINISTRATION, ORAL;
ATRIAL FIBRILLATION;
BONE DENSITY CONSERVATION AGENTS;
DIPHOSPHONATES;
ESOPHAGEAL NEOPLASMS;
HIP FRACTURES;
HUMANS;
JAW;
OSTEONECROSIS;
PAIN;
|
EID: 60749134680
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2009.128 Document Type: Short Survey |
Times cited : (13)
|
References (0)
|